Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Marco F. Pagnoni"'
Autor:
Eddy Ziani, G. Frank Liu, Jon E. Stek, Florence Boisnard, Timo Vesikari, Marco F. Pagnoni, Katleen Poschet, Sheryl A. Flores, Andrew W. Lee, Stéphane Thomas, Thomas Becker, Jin Xu, André Vertruyen
Publikováno v:
Pediatric Infectious Disease Journal. 36:209-215
Combination vaccines simplify vaccination visits and improve coverage and timeliness. Diphtheria-tetanus toxoids-acellular pertussis 5, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b (DTaP5-HB-IPV-Hib) is a new investig
Autor:
Eva Kimby, Marco F. Pagnoni, Janie Parrino, Ivan S. F. Chan, Shelly A. McNeil, Steven J. Lawrence, Yanli Zhao, Susan S. Kaplan, Jon E. Stek
Publikováno v:
Vaccine. 35(14)
Background Immunocompromised patients can experience significant morbidity and occasional mortality from complications associated with herpes zoster (HZ), but live attenuated HZ vaccine is contraindicated for these patients. Inactivated zoster vaccin
Autor:
Jon E. Stek, Eddy Ziani, G. Frank Liu, Florence Boisnard, Sven Arne Silfverdal, Marco F. Pagnoni, Stéphane Thomas, Giancarlo Icardi, Andrew W. Lee, Jin Xu, Sheryl Flores, Timo Vesikari
Publikováno v:
Vaccine. 34(33)
Combination vaccines simplify vaccination visits and improve coverage and timeliness. DTaP5-HB-IPV-Hib is a new investigational, fully-liquid, combination vaccine designed to protect against 6 infectious diseases, including 5 pertussis antigens and O
Autor:
Adam J. Simon, Jay A. Grobler, Osvaldo A. Flores, Giacomo Paonessa, Marco F. Pagnoni, Edward M. Murray, Eric J. Markel
Publikováno v:
Journal of Virology. 77:2928-2935
Progress toward development of better therapies for the treatment of hepatitis C virus (HCV) infection has been hampered by poor understanding of HCV biology and the lack of biological assays suitable for drug screening. Here we describe a powerful H
Autor:
Jon E. Stek, Marco F. Pagnoni, Janie Parrino, Jeffrey G. Smith, Ivan S. F. Chan, Myron J. Levin, Jeffrey L. Silber, Jin Xu, Stephen K. Tyring
Varicella-zoster virus (VZV)-specific cell-mediated immunity (CMI) responses were compared over time following an episode of herpes zoster (HZ) with those of age-, race-, and gender-matched healthy controls (HC) without HZ, using a validated gamma in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24f6264543547d61c08e87656dd13f20
https://europepmc.org/articles/PMC3428399/
https://europepmc.org/articles/PMC3428399/
Autor:
Jon E. Stek, C. Raina MacIntyre, Shu-Chih Su, Marco F. Pagnoni, Jin Xu, Jeffrey L. Silber, Bernadette V Campbell, Paula W. Annunziato, Tony Egerton, Janie Parrino, Malcolm McCaughey, Ivan S. F. Chan
Publikováno v:
Human vaccines. 6(11)
This study evaluated safety & immunogenicity of ZOSTAVAX® (zoster vaccine: ZV) administered concomitantly versus nonconcomitantly with PNEUMOVAX® 23 (pneumococcal vaccine: PPV23). This randomized, double-blind, placebo-controlled study enrolled 473
Autor:
Steven J. Lawrence, Andrea Velardi, Janie Parrino, Shelly A. McNeil, Ingi Lee, Eva Kimby, Marco F. Pagnoni, Ivan H. Chan, Jon E. Stek, Robert F. Betts, Yanli Zhao
Publikováno v:
Blood. 122:2290-2290
Background Herpes zoster (HZ) incidence is higher in patients with hematologic malignancies (HM) (25-100 cases/1000 person-years) than in the general population (3-5 cases/1000 person-years). This immunocompromised population can experience significa
Autor:
Yuri Ivashchenko, Kun Guo, D Krolikowski, K.T. Yu, Clark Kenneth L, G Searfoss, M Jaye, Marco F. Pagnoni, C Franks
Publikováno v:
Cell death and differentiation. 8(4)
It has been shown that oxygen deprivation results in apoptotic cell death, and that hypoxia inducible factor 1 (HIF1) and the tumor suppressor p53 play key roles in this process. However, the molecular mechanism through which hypoxia and HIF1 induce